Total investments received (USD): 4.95m
Round value (USD): N/A
Round investors:
NRW.BANK
Company: CEVEC Pharmaceuticals






Belgium
Netherlands
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
France
Ireland
Italy
Portugal
Spain